Menu
Apply

Cancer Genetic and Genomic Testing

Apply

Co-Pay Relief Program Fund Notices

Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!

Get Notified


Status
Open
Fund Type

Co-pay, Co-Insurance & Deductible

Maximum Award Level

$250 Per Year

Eligibility Requirements
  • Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
  • Insurance Requirements Patient must be insured, however insurance does not have to cover the cancer genetic and genomic testing for which patient seeks assistance.
  • Must reside and receive treatment in the United States.

About Cancer Genetic and Genomic Testing

Genetics is the study of single genes and their role in the way traits or conditions are passed from one generation to the next. Genetic alterations can be inherited from one’s parents, caused by environmental factors, or occur during natural processes such as cell division, and account for 90 to 95 percent of all cases of cancer. Genetic testing involves looking at the specific inherited changes or mutations in the chromosomes, genes or proteins that humans are born with and their role in the ways traits or conditions are passed from one generation to the next. Genetic testing can also be used to examine mutations that have been acquired in genes after birth.

Cancer is a group of diseases caused by changes in DNA that alter cell behavior, causing uncontrollable growth and malignancy. These abnormalities can take many forms, including DNA mutations, rearrangements, deletions, amplifications, and the addition or removal of chemical marks.

Genomics describes the study of all parts of an organism’s genes. Genomic tumor testing can tell one type of cancer or subtype of the cancer from another, identify the DNA alterations that are driving the growth of a particular tumor, as well as gain a better understanding of the molecular basis of cancer growth, metastasis, and/or drug resistance. Precision medicine uses the specific information about the tumor to help diagnose, select optimal therapies based on the context of the patient’s genetic profile, determine how well a treatment is working or make a prognosis.

Cancer Genetic and Genomic Testing Resources
Medication & Financial Assistance Resources
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites. PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided. The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.
Apply